NGAL (Neutrophil Gelatinase-Associated Lipocalin) as an early biomarker of nephropathy in patients with type 2 diabetes

Authors:

Abstract
No abstract available
Funding Information
  • organization for the submitted work

This publication has 23 references indexed in Scilit: